Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Insights into HPLC-MS/MS Analysis, Antioxidant and Cytotoxic Activity of Astragalus fruticosus against Different Types of Cancer Cell Lines

MF. Dekinash, TM. Okda, EK. Elmahallawy, FK. El-Fiky, GAEH. Omran, E. Svajdlenka, N. Dahran, MF. El-Khadragy, WA. Al-Megrin, EMBA. El Naggar

. 2022 ; 15 (11) : . [pub] 20221114

Status not-indexed Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22031287

Plants from the genus Astragalus are gaining attention for their pharmacological importance. However, the information available regarding the HPLC-MS/MS chemical profile of A. fruticosus is inadequate. In this study, we performed HPLC-MS/MS analysis using electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). We tentatively identified 11 compounds in the A. fruticosus methanolic extract, including five flavonoidal and six saponin glycosides. The extract showed moderate antioxidant activity with 21.05% reduction in DPPH UV absorption. The preliminary cytotoxic screening against seven human cancer cell lines using 100 μg/mL extract showed prominent cytotoxic potential against colorectal cancer HCT-116 with 3.368% cell viability. It also showed moderate cytotoxic potential against prostate (DU-145), ovarian (SKOV-3) and lung (A-549) cancer cell lines with cell viability of 14.25%, 16.02% and 27.24%, respectively. The IC50 of the total extract against HCT-116 and DU-145 cell lines were 7.81 μg/mL and 40.79 μg/mL, respectively. The observed cytotoxicity of the total methanolic extract from the leaves against colorectal cancer might facilitate future investigations on cytotoxic agent(s) for disease management.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031287
003      
CZ-PrNML
005      
20230127131118.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph15111406 $2 doi
035    __
$a (PubMed)36422536
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dekinash, Mohamed Fayez $u Department of Pharmacognosy, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt $1 https://orcid.org/0000000189581187
245    10
$a Insights into HPLC-MS/MS Analysis, Antioxidant and Cytotoxic Activity of Astragalus fruticosus against Different Types of Cancer Cell Lines / $c MF. Dekinash, TM. Okda, EK. Elmahallawy, FK. El-Fiky, GAEH. Omran, E. Svajdlenka, N. Dahran, MF. El-Khadragy, WA. Al-Megrin, EMBA. El Naggar
520    9_
$a Plants from the genus Astragalus are gaining attention for their pharmacological importance. However, the information available regarding the HPLC-MS/MS chemical profile of A. fruticosus is inadequate. In this study, we performed HPLC-MS/MS analysis using electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). We tentatively identified 11 compounds in the A. fruticosus methanolic extract, including five flavonoidal and six saponin glycosides. The extract showed moderate antioxidant activity with 21.05% reduction in DPPH UV absorption. The preliminary cytotoxic screening against seven human cancer cell lines using 100 μg/mL extract showed prominent cytotoxic potential against colorectal cancer HCT-116 with 3.368% cell viability. It also showed moderate cytotoxic potential against prostate (DU-145), ovarian (SKOV-3) and lung (A-549) cancer cell lines with cell viability of 14.25%, 16.02% and 27.24%, respectively. The IC50 of the total extract against HCT-116 and DU-145 cell lines were 7.81 μg/mL and 40.79 μg/mL, respectively. The observed cytotoxicity of the total methanolic extract from the leaves against colorectal cancer might facilitate future investigations on cytotoxic agent(s) for disease management.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Okda, Tarek M $u Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt
700    1_
$a Elmahallawy, Ehab Kotb $u Department of Zoonoses, Faculty of Veterinary Medicine, Sohag University, Sohag 82524, Egypt $1 https://orcid.org/0000000344843678
700    1_
$a El-Fiky, Fathy Kandil $u Department of Pharmacognosy, Faculty of Pharmacy, Delta University for Science and Technology, Mansoura 35511, Egypt
700    1_
$a Omran, Gamal Abd El Hay $u Department of Biochemistry, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt $1 https://orcid.org/0000000216098802
700    1_
$a Svajdlenka, Emil $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, 60300 Brno, Czech Republic
700    1_
$a Dahran, Naief $u Department of Anatomy, Faculty of Medicine, University of Jeddah, Jeddah 21959, Saudi Arabia $1 https://orcid.org/0000000335608166
700    1_
$a El-Khadragy, Manal F $u Department of biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia $1 https://orcid.org/0000000154576791
700    1_
$a Al-Megrin, Wafa A $u Department of biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia $1 https://orcid.org/0000000180118153
700    1_
$a El Naggar, El Moataz Bellah Ali $u Department of Pharmacognosy, Faculty of Pharmacy, Damanhour University, Damanhour 22511, Egypt $1 https://orcid.org/0000000331491677
773    0_
$w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 15, č. 11 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36422536 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131110 $b ABA008
999    __
$a ok $b bmc $g 1889440 $s 1182620
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 15 $c 11 $e 20221114 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
LZP    __
$a Pubmed-20230119

Find record

Citation metrics

Archiving options